tradingkey.logo
搜索

SNWV

SNWV
添加自选
10.630USD
+0.030+0.28%
收盘 07/02, 13:00美东报价延迟15分钟
91.36M总市值
5.51市盈率 TTM

TradingKey SNWV股票评分

单位: USD 更新时间: 2026-07-01

操作建议

SANUWAVE Health Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名82/204位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价47.00。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

SNWV评分

相关信息

行业排名
82 / 204
全市场排名
216 / 4564
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

SNWV亮点

亮点风险
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
业绩高增长
公司营业收入稳步增长,连续3年增长115.96%
业绩增长期
公司处于发展阶段,最新年度总收入44.05M美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值5.50,处于3年历史高位
机构加仓
最新机构持股5.44M股,环比增加9.37%

分析师目标

根据 0 位分析师
--
评级
47.000
目标均价
+188.17%
涨幅空间